--- title: "300584.SZ (300584.SZ) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/300584.SZ/news.md" symbol: "300584.SZ" name: "300584.SZ" parent: "https://longbridge.com/en/quote/300584.SZ.md" datetime: "2026-03-05T00:53:14.358Z" locales: - [en](https://longbridge.com/en/quote/300584.SZ/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/300584.SZ/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/300584.SZ/news.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/300584.SZ/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/300584.SZ/news.md) # 300584.SZ (300584.SZ) — Related News ### [Hicin Pharmaceutical: The company's VC project has begun trial production and still needs to go through the capacity ramp-up process](https://longbridge.com/en/news/270766630.md) *2025-12-25T03:42:48.000Z* > On December 25th, Hicin Pharmaceutical stated on the interactive platform that the company's VC project has begun trial ### [Hicin Pharmaceutical: The company's injectable Labetalol has been included in the national medical insurance catalog](https://longbridge.com/en/news/268916637.md) *2025-12-08T08:10:06.000Z* > Hicin Pharmaceutical announced that its injectable Labetalol Hydrochloride (50mg) has successfully renewed its contract, ### [Hicin Pharmaceutical: The company's VC project is currently preparing for production before launch](https://longbridge.com/en/news/268035843.md) *2025-12-01T08:22:41.000Z* > On December 1st, Hicin Pharmaceutical stated on the interactive platform that the company's VC project is in the prepara ### [](https://longbridge.com/en/news/266107734.md) *2025-11-17T02:17:38.000Z* > The A-share innovative drug sector continues to weaken, with Hicin Pharmaceutical and Chimin falling over 7%, while Stai ### [Dragon and Tiger List | Quantitative fund seat of 35.9842 million listed, Hicin Pharmaceutical first board 20CM limit up](https://longbridge.com/en/news/265891668.md) *2025-11-14T10:14:19.000Z* > On November 14th, Hicin Pharmaceutical (300584) surged to the daily limit, with a stock price of 71.9 yuan, an increase ### [Hicin Pharmaceutical: Methanesulfonic Acid New Suximethonium Injection has obtained drug registration approval](https://longbridge.com/en/news/265868023.md) *2025-11-14T08:20:03.000Z* > According to the Zhitong Finance APP, Hicin Pharmaceutical announced that the company recently received the "Drug Regist ### [The concept of solid-state batteries fluctuates and rises, ZHONGYI and others hit the daily limit](https://longbridge.com/en/news/265846716.md) *2025-11-14T05:11:41.000Z* > The concept of solid-state batteries is fluctuating upward, with ZHONGYI, HFCC, and Guosheng Technology hitting the dail